Literature DB >> 34326377

Pseudoboehmite as a drug delivery system for acyclovir.

Renato Meneghetti Peres1, Jéssica Maiara Leme Sousa1, Mariana Oliva de Oliveira2, Maura Vincenza Rossi1, Rene Ramos de Oliveira3, Nelson Batista de Lima3, Ayrton Bernussi4, Juliusz Warzywoda5, Bruno Sarmento6, Antonio Hortencio Munhoz7.   

Abstract

Herpes simplex virus is among the most prevalent sexually transmitted infections. Acyclovir is a potent, selective inhibitor of herpes viruses and it is indicated for the treatment and management of recurrent cold sores on the lips and face, genital herpes, among other diseases. The problem of the oral bioavailability of acyclovir is limited because of the low permeability across the gastrointestinal membrane. The use of nanoparticles of pseudoboehmite as a drug delivery system in vitro assays is a promising approach to further the permeability of acyclovir release. Here we report the synthesis of high purity pseudoboehmite from aluminium nitrate and ammonium hydroxide containing nanoparticles, using the sol-gel method, as a drug delivery system to improve the systemic bioavailability of acyclovir. The presence of pseudoboehmite nanoparticles were verified by infrared spectroscopy, transmission electron microscopy, and X-ray diffraction techniques. In vivo tests were performed with Wistar rats to compare the release of acyclovir, with and without the addition of pseudoboehmite. The administration of acyclovir with the addition of pseudoboehmite increased the drug content by 4.6 times in the plasma of Wistar rats after 4 h administration. We determined that the toxicity of pseudoboehmite is low up to 10 mg/mL, in gel and the dried pseudoboehmite nanoparticles.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34326377     DOI: 10.1038/s41598-021-94325-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  15 in total

1.  Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.

Authors:  Yasuhiro Ikawa; Toshihiro Fujiki; Ryosei Nishimura; Kazuhiro Noguchi; Eri Koshino; Akiko Fujiki; Masaki Fukuda; Rie Kuroda; Shintaro Mase; Raita Araki; Hideaki Maeba; Kimiyasu Shiraki; Akihiro Yachie
Journal:  J Infect Chemother       Date:  2018-07-29       Impact factor: 2.211

2.  Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis.

Authors:  Emily Baumrin; Matthew P Cheng; Sanjat Kanjilal; Vincent T Ho; Nicolas C Issa; Lindsey R Baden
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-17       Impact factor: 5.742

Review 3.  Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

Authors:  R E Tanzi; R D Moir; S L Wagner
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

4.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

Review 5.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

6.  Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.

Authors:  M A Wozniak; A P Mee; R F Itzhaki
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

7.  The combination of acyclovir and dexamethasone protects against Alzheimer's disease-related cognitive impairments in mice.

Authors:  Zhang Hui; Yuan Zhijun; Yan Yushan; Chen Liping; Zhou Yiying; Zhang Difan; Choi Tony Chunglit; Cui Wei
Journal:  Psychopharmacology (Berl)       Date:  2020-03-27       Impact factor: 4.530

8.  Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.

Authors:  William A Eimer; Deepak Kumar Vijaya Kumar; Nanda Kumar Navalpur Shanmugam; Alex S Rodriguez; Teryn Mitchell; Kevin J Washicosky; Bence György; Xandra O Breakefield; Rudolph E Tanzi; Robert D Moir
Journal:  Neuron       Date:  2018-07-11       Impact factor: 17.173

9.  Tailor-made charge-conversional nanocomposite for pH-responsive drug delivery and cell imaging.

Authors:  Yan Chen; Kelong Ai; Yanlan Liu; Lehui Lu
Journal:  ACS Appl Mater Interfaces       Date:  2013-12-12       Impact factor: 9.229

10.  Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review.

Authors:  Keenan Piper; Haidn Foster; Brandon Gabel; Burt Nabors; Charles Cobbs
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

View more
  2 in total

1.  Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release.

Authors:  He Lv; Shiri Guo; Gaoyi Zhang; Wanli He; Yonghui Wu; Deng-Guang Yu
Journal:  Polymers (Basel)       Date:  2021-12-07       Impact factor: 4.329

2.  Electrospun Hybrid Films for Fast and Convenient Delivery of Active Herb Extracts.

Authors:  Shiri Guo; Wenlai Jiang; Liangfei Shen; Gaoyi Zhang; Yiman Gao; Yaoyao Yang; Deng-Guang Yu
Journal:  Membranes (Basel)       Date:  2022-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.